» Articles » PMID: 38166927

Ferroptosis: a Promising Candidate for Exosome-mediated Regulation in Different Diseases

Overview
Publisher Biomed Central
Date 2024 Jan 3
PMID 38166927
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a newly discovered form of cell death that is featured in a wide range of diseases. Exosome therapy is a promising therapeutic option that has attracted much attention due to its low immunogenicity, low toxicity, and ability to penetrate biological barriers. In addition, emerging evidence indicates that exosomes possess the ability to modulate the progression of diverse diseases by regulating ferroptosis in damaged cells. Hence, the mechanism by which cell-derived and noncellular-derived exosomes target ferroptosis in different diseases through the system Xc/GSH/GPX4 axis, NAD(P)H/FSP1/CoQ10 axis, iron metabolism pathway and lipid metabolism pathway associated with ferroptosis, as well as its applications in liver disease, neurological diseases, lung injury, heart injury, cancer and other diseases, are summarized here. Additionally, the role of exosome-regulated ferroptosis as an emerging repair mechanism for damaged tissues and cells is also discussed, and this is expected to be a promising treatment direction for various diseases in the future. Video Abstract.

Citing Articles

Portable Cell Tracking Velocimetry for Quantification of Intracellular Fe Concentration of Blood Cells.

Tran L, Paz Gonzalez K, Choe H, Wu X, Strayer J, Iyer P Micromachines (Basel). 2025; 16(2).

PMID: 40047598 PMC: 11857336. DOI: 10.3390/mi16020126.


Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair.

Kundu D, Shin S, Chilian W, Dong F Int J Mol Sci. 2025; 25(24.

PMID: 39769256 PMC: 11727646. DOI: 10.3390/ijms252413494.


Exosomes in esophageal cancer: a promising frontier for liquid biopsy in diagnosis and therapeutic monitoring.

Zihan R, Jingsi C, Lingwen D, Xin L, Yan Z Front Pharmacol. 2025; 15:1459938.

PMID: 39741631 PMC: 11685219. DOI: 10.3389/fphar.2024.1459938.


Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy.

Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X Cell Prolif. 2024; 58(3):e13779.

PMID: 39624950 PMC: 11882765. DOI: 10.1111/cpr.13779.


References
1.
Xiao W, Beibei F, Guangsi S, Yu J, Wen Z, Xi H . Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass. J Endocrinol. 2015; 226(3):121-34. DOI: 10.1530/JOE-14-0657. View

2.
Li K, Xu K, He Y, Yang Y, Tan M, Mao Y . Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer. ACS Nano. 2023; 17(5):4667-4687. DOI: 10.1021/acsnano.2c10893. View

3.
Wu L, Zhou J, Zhou W, Huang X, Chen Q, Wang W . Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo. Pathol Res Pract. 2021; 220:153270. DOI: 10.1016/j.prp.2020.153270. View

4.
Gao Y, Li J, Xi H, Cui J, Zhang K, Zhang J . Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway. Br J Cancer. 2020; 122(12):1837-1847. PMC: 7283337. DOI: 10.1038/s41416-020-0827-5. View

5.
Thomas D, Apovian C . Macrophage functions in lean and obese adipose tissue. Metabolism. 2017; 72:120-143. PMC: 5516622. DOI: 10.1016/j.metabol.2017.04.005. View